Synergy CHC (SNYR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
17 Apr, 2026Executive summary
The 2026 annual meeting will be held virtually on June 29, 2026, with stockholders voting on key proposals including director elections, auditor ratification, equity plan amendments, warrant share issuance, and a reverse stock split.
Stockholders of record as of April 24, 2026, are eligible to vote, with 14,781,883 shares outstanding.
Proxy materials are primarily delivered electronically to conserve resources and reduce costs.
Voting matters and shareholder proposals
Proposals include: election of five directors, ratification of RBSM LLP as auditor, amendment to the 2024 Equity Incentive Plan (increase to 35,000,000 shares and allow repricing), approval of full issuance of shares under the Lender Warrant, and approval of a reverse stock split up to 1-for-40.
Board recommends voting FOR all proposals.
Voting results will be published in a Form 8-K within four business days of the meeting.
Board of directors and corporate governance
Five nominees for director: Jack Ross, Alfred Baumeler, J. Paul SoRelle, Nitin Kaushal, and Teresa Thompson, each with significant industry and leadership experience.
Board committees: Audit (Kaushal, SoRelle, Thompson), Compensation (Kaushal, SoRelle, Thompson), Nominating and Corporate Governance (SoRelle, Kaushal, Thompson).
All committee members meet independence and financial literacy requirements.
Code of Business Ethics and Conduct applies to all directors, officers, and employees.
Latest events from Synergy CHC
- 2025 revenue and margins fell on one-time charges, but 2026 starts with strong beverage growth.SNYR
Q4 20251 Apr 2026 - Q3 sales fell on rebranding, but profitability, liquidity, and growth plans remain strong.SNYR
Q3 202411 Jan 2026 - All director nominees and key proposals were approved, with results to be filed with the SEC.SNYR
AGM 20256 Jan 2026 - Profitability maintained amid revenue decline; IPO and new launches set stage for 2025 growth.SNYR
Q4 202426 Dec 2025 - Shelf registration for $100M in securities, with $5.69M ATM offering to fund growth and expansion.SNYR
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, auditor, equity plan, and preferred stock authorization.SNYR
Proxy Filing2 Dec 2025 - Stockholders to vote on director elections, auditor, equity plan, and preferred stock authorization.SNYR
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, auditor, equity plan expansion, and preferred stock authorization.SNYR
Proxy Filing2 Dec 2025 - Health and wellness firm targets Nasdaq IPO to fund growth amid strong 2023 results and high debt.SNYR
Registration Filing30 Nov 2025